Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: effectiveness and value
Institute for Clinical and Economic Review (ICER)
Record ID 32018002637
English
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://icer.org/assessment/high-cholesterol-2021/#timeline
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Hypercholesterolemia
- Drug Therapy, Combination
- Cardiovascular Diseases
- Hyperlipoproteinemia Type II
- Anticholesteremic Agents
- Hypolipidemic Agents
- Dicarboxylic Acids
- RNA, Small Interfering
- Cost-Benefit Analysis
- PCSK9 Inhibitors
Contact
Organisation Name:
Institute for Clinical and Economic Review
Contact Address:
101 Merrimac St., 10th FL., Boston MA, USA 02114, Tel: (617) 724-4445 , Fax: (617) 726-9414
Contact Name:
info@icer-review.org
Contact Email:
info@icer-review.org
Copyright:
<p>Institute for Clinical and Economic Review (ICER)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.